Corporate Compliance

Lidocaine gel poses serious risks, FDA states

Mammography Regulation and Reimbursement Report, March 1, 2009

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Mammography Regulation and Reimbursement Report.

The FDA issued a public health advisory in January warning facilities that patients who use topical anesthetics to reduce pain associated with medical tests, including mammography, may expose themselves to potentially serious or deadly health risks.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Mammography Regulation and Reimbursement Report.

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Mammography Regulation and Reimbursement Report

    Comply with FDA regulations and interpret the Mammography Quality Standards Act with Mammography Regulation Report.

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Laboratory Compliance Insider

    Each month with Laboratory Compliance Insider you get more of our exclusive working tools: model guidelines, policies...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

Most Popular

Related Articles